| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 393-407, Copyright © 1996 by Endocrine Society
ARTICLES |
P Prendergast, Z Pan and DP Edwards
Department of Pathology, University of Colorado Health Sciences Center Denver 80262, USA.
We have used circular permutation and phasing electrophoretic mobility shift assays to determine the ability of the A and B forms of human progesterone receptor (PR) to bend target DNA. Studies were done with baculovirus-expressed full-length receptors purified to apparent homogeneity. By circular permutation analysis, both forms of PR induced substantial distortions in the structure of target DNA with calculated distortion angles (alpha D) of 57 degrees for PR-A and 84 degrees for PR-B. The apparent bend centers for both forms of PR were similarly located a few base pairs (-4 to -2 bp) from the middle of the progesterone response element. No differences were detected in the magnitude of distortion or apparent bend centers when PR was bound to hormone agonist (R5020) or the antagonist RU486. Phasing analysis, which can determine the orientation of a DNA bend, revealed that both forms of PR mediated directional bends toward the major groove of the DNA helix. Calculated directed bend angles (alpha B) were 40 degrees for PR-B and 31 degrees for PR-A. The chromatin high mobility group protein HMG-1, which acts as an accessory factor to enhance the binding affinity of purified PR for progesterone response elements, had minimal influence on PR-mediated DNA bending. This result, taken together with the fact that HMG-1 can form a ternary complex with PR and DNA, is consistent with the conclusion that HMG-1 facilitates PR binding by stabilizing a receptor-induced DNA conformation that is required for assembly of a high affinity PR-DNA complex. The results of this study also suggest that DNA bending may be coupled to transcriptional regulation since PR-B is generally a stronger transcriptional activator than PR-A and also mediates a larger bend in target DNA than PR-A.
This article has been cited by other articles:
![]() |
K. D. Connaghan-Jones, A. F. Heneghan, M. T. Miura, and D. L. Bain Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function PNAS, February 13, 2007; 104(7): 2187 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Schultz, M. A. Loven, V. M. S. Melvin, D. P. Edwards, and A. M. Nardulli Differential Modulation of DNA Conformation by Estrogen Receptors alpha and beta J. Biol. Chem., March 1, 2002; 277(10): 8702 - 8707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasaki, A. Dharia, B. R. Oh, Y. Tanaka, S.-i. Fujimoto, and R. Dahiya Progesterone Receptor B Gene Inactivation and CpG Hypermethylation in Human Uterine Endometrial Cancer Cancer Res., January 1, 2001; 61(1): 97 - 102. [Abstract] [Full Text] |
||||
![]() |
C. C. Zhang, S. Krieg, and D. J. Shapiro HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells Mol. Endocrinol., April 1, 1999; 13(4): 632 - 643. [Abstract] [Full Text] |
||||
![]() |
S. Um, M. Harbers, A. Benecke, B. Pierrat, R. Losson, and P. Chambon Retinoic Acid Receptors Interact Physically and Functionally with the T:G Mismatch-specific Thymine-DNA Glycosylase J. Biol. Chem., August 14, 1998; 273(33): 20728 - 20736. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Boonyaratanakornkit, V. Melvin, P. Prendergast, M. Altmann, L. Ronfani, M. E. Bianchi, L. Taraseviciene, S. K. Nordeen, E. A. Allegretto, and D. P. Edwards High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells Mol. Cell. Biol., August 1, 1998; 18(8): 4471 - 4487. [Abstract] [Full Text] |
||||
![]() |
T. Gao and M. J. McPhaul Functional Activities of the A and B Forms of the Human Androgen Receptor in Response to Androgen Receptor Agonists and Antagonists Mol. Endocrinol., May 1, 1998; 12(5): 654 - 663. [Abstract] [Full Text] |
||||
![]() |
L. E. Romine, J. R. Wood, L. A. Lamia, P. Prendergast, D. P. Edwards, and A. M. Nardulli The High Mobility Group Protein 1 Enhances Binding of the Estrogen Receptor DNA Binding Domain to the Estrogen Response Element Mol. Endocrinol., May 1, 1998; 12(5): 664 - 674. [Abstract] [Full Text] |
||||
![]() |
C. S. Verrier, N. Roodi, C. J. Yee, L. R. Bailey, R. A. Jensen, M. Bustin, and F. F. Parl High-Mobility Group (HMG) Protein HMG-1 and TATA-Binding Protein-Associated Factor TAFII30 Affect Estrogen Receptor-Mediated Transcriptional Activation Mol. Endocrinol., July 1, 1997; 11(8): 1009 - 1019. [Abstract] [Full Text] |
||||
![]() |
S. Chavez and M. Beato Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter PNAS, April 1, 1997; 94(7): 2885 - 2890. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |